-
Signature
-
/s/ Carolyn Tang, Attorney-in-Fact
-
Stock symbol
-
RCUS
-
Transactions as of
-
Nov 7, 2025
-
Transactions value $
-
-$954,066
-
Form type
-
4
-
Date filed
-
11/12/2025, 04:04 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Jarrett Jennifer |
Chief Operating Officer |
C/O ARCUS BIOSCIENCES, INC., 3928 POINT EDEN WAY, HAYWARD |
/s/ Carolyn Tang, Attorney-in-Fact |
2025-11-12 |
0001671311 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RCUS |
Common Stock |
Options Exercise |
$61.7K |
+50.3K |
+23.48% |
$1.23 |
265K |
Nov 7, 2025 |
Direct |
F1 |
| transaction |
RCUS |
Common Stock |
Sale |
-$954K |
-50.3K |
-19.01% |
$18.97 |
214K |
Nov 7, 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RCUS |
Stock Option (Right to Buy) |
Options Exercise |
-$61.7K |
-50.3K |
-38.43% |
$1.23 |
80.6K |
Nov 7, 2025 |
Common Stock |
50.3K |
$1.23 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: